Challenges from atypical pathogens in diagnosis and treatment of community-acquired pneumonia
Atypical pathogens in the community-acquired pneumonia
References
Basarab M, Macrae MB, Curtis CM. Atypical pneumonia. Curr Opin Pulm Med 2014;20:247-51.
Reimann HA. An acute infection of the respiratory tract with atypical pneumonia. J Am Med Assoc 1984;251:936-44.
Marrie TJ, Haldane EV, Noble MA, Faulkner RS, Martin RS, Lee SH. Causes of atypical pneumonia: Results of a 1-year prospective study. Can Med Assoc J 1981;125:1118-23.
van den Hoogen BG, de Jong JC, Groen J, Kuiken T, de Groot R, Fouchier RA, et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 2001;7:719-24.
Plouffe JF. Importance of atypical pathogens of community acquired pneumonia. Clin Infect Dis 2000;31 Suppl 2:S35-9.
Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, et al. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med 2007;175:1086-93.
Okazaki N, Narita M, Yamada S, Izumikawa K, Umetsu M, Kenri T, et al. Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro. Microbiol Immunol 2001;45:617-20.
Zhao F, Liu G, Wu J, Cao B, Tao X, He L, et al. Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012. Antimicrob Agents Chemother 2013;57:1521-3.
Miyashita N, Oka M, Atypical Pathogen Study Group, Kawai Y, Yamaguchi T, Ouchi K. Macrolide-resistant Mycoplasma pneumoniae in adults with community-acquired pneumonia. Int J Antimicrob Agents 2010;36:384-5.
Spuesens EB, Meijer A, Bierschenk D, Hoogenboezem T, Donker GA, Hartwig NG, et al. Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae in respiratory specimens collected between 1997 and 2008 in The Netherlands. J Clin Microbiol 2012;50:1999-2004.
Uldum SA, Bangsborg JM, Gahrn-Hansen B, Ljung R, Mølvadgaard M, Føns Petersen R, et al. Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011. Euro Surveill 2012;17:pii: 20073.
Pereyre S, Touati A, Petitjean-Lecherbonnier J, Charron A, Vabret A, Bébéar C. The increased incidence of Mycoplasma pneumoniae in France in 2011 was polyclonal, mainly involving M. pneumoniae type 1 strains. Clin Microbiol Infect 2013;19:E212-7.
Yamada M, Buller R, Bledsoe S, Storch GA. Rising rates of macrolide-resistant Mycoplasma pneumoniae in the central United States. Pediatr Infect Dis J 2012;31:409-10.
Pereyre S, Charron A, Hidalgo-Grass C, Touati A, Moses AE, Nir-Paz R, et al. The spread of Mycoplasma pneumoniae is polyclonal in both an endemic setting in France and in an epidemic setting in Israel. PLoS One 2012;7:e38585.
Hanada S, Morozumi M, Takahashi Y, Mochizuki S, Sato T, Suzuki S, et al. Community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in adults. Intern Med 2014;53:1675-8.
Chedid MB, Chedid MF, Ilha DO, Bozzetti MC, Chaves L, Griza D, et al. Community-acquired pneumonia by Chlamydophila pneumoniae: A clinical and incidence study in Brazil. Braz J Infect Dis 2007;11:75-82.
Reechaipichitkul W, Saelee R, Lulitanond V. Prevalence and clinical features of Chlamydia pneumoniae pneumonia at Srinagarind Hospital, Khon Kaen, Thailand. Southeast Asian J Trop Med Public Health 2005;36:151-5.
Zhong NS, Sun T, Zhuo C, D′Souza G, Lee SH, Lan NH, et al. Ceftaroline fosamil versus ceftriaxone for the treatment of Asian patients with community-acquired pneumonia: A randomised, controlled, double-blind, phase 3, non-inferiority with nested superiority trial. Lancet Infect Dis 2014.
Burillo A, Bouza E. Chlamydophila pneumoniae. Infect Dis Clin North Am 2010;24:61-71.
Benitez AJ, Winchell JM. Clinical application of a multiplex real-time PCR assay for simultaneous detection of Legionella species, Legionella pneumophila, and Legionella pneumophila serogroup 1. J Clin Microbiol 2013;51:348-51.
European Centre for Disease Prevention and Control. Legionnaires′ disease in Europe, 2011. Stockholm: ECDC; 2013.
Centers for Disease Control and Prevention (CDC). Influenza vaccination coverage among health-care personnel - United States, 2010-11 influenza season. MMWR Morb Mortal Wkly Rep 2011;60:1073-7.
Helbig JH, Uldum SA, Bernander S, Lück PC, Wewalka G, Abraham B, et al. Clinical utility of urinary antigen detection for diagnosis of community-acquired, travel-associated, and nosocomial Legionnaires′ disease. J Clin Microbiol 2003;41:838-40.
Svarrer CW, Lück C, Elverdal PL, Uldum SA. Immunochromatic kits Xpect Legionella and BinaxNOW Legionella for detection of Legionella pneumophila urinary antigen have low sensitivities for the diagnosis of Legionnaires′ disease. J Med Microbiol 2012;61:213-7.
Elverdal PL, Svarrer CW, Jørgensen CS, Skovsted IC, Uldum SA. Development and validation of ELISA for detection of antibodies to Legionella pneumophila serogroup 1, 3 and 6 in human sera. J Microbiol Methods 2011;86:298-303.
Fields BS, Benson RF, Besser RE. Legionella and Legionnaires′ disease: 25 years of investigation. Clin Microbiol Rev 2002;15:506-26.
Engel MF, van Manen L, Hoepelman AI, Thijsen S, Oosterheert JJ. Diagnostic, therapeutic and economic consequences of a positive urinary antigen test for Legionella spp. in patients admitted with community-acquired pneumonia: A 7-year retrospective evaluation. J Clin Pathol 2013;66:797-802.
von Baum H, Ewig S, Marre R, Suttorp N, Gonschior S, Welte T, et al. Community-acquired Legionella pneumonia: New insights from the German competence network for community acquired pneumonia. Clin Infect Dis 2008;46:1356-64.
Arancibia F, Cortes CP, Valdés M, Cerda J, Hernández A, Soto L, et al. Importance of Legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago, Chile. Chest 2014;145:290-6.
Chen Y, Tateda K, Fujita K, Ishii T, Ishii Y, Kimura S, et al. Sequential changes of Legionella antigens and bacterial load in the lungs and urines of a mouse model of pneumonia. Diagn Microbiol Infect Dis 2010;66:253-60.
Tateda K, Deng JC, Moore TA, Newstead MW, Paine R 3 rd , Kobayashi N, et al. Hyperoxia mediates acute lung injury and increased lethality in murine Legionella pneumonia: The role of apoptosis. J Immunol 2003;170:4209-16.
Cheng VC, Lau SK, Woo PC, Yuen KY. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev 2007;20:660-94.
Fineberg HV. Pandemic preparedness and response - lessons from the H1N1 influenza of 2009. N Engl J Med 2014;370:1335-42.
Simonsen L, Spreeuwenberg P, Lustig R, Taylor RJ, Fleming DM, Kroneman M, et al. Global mortality estimates for the 2009 Influenza Pandemic from the GLaMOR project: A modeling study. PLoS Med 2013;10:e1001558.
Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 2013;368:1888-97.
Chen Y, Liang W, Yang S, Wu N, Gao H, Sheng J, et al. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: Clinical analysis and characterisation of viral genome. Lancet 2013;381:1916-25.
Yang F, Wang J, Jiang L, et al. A fatal case caused by novel H7N9 avian influenza A virus in China. Emerg Microbes Infect 2013;2:e19.
Jie Z, Xie J, He Z, Song Y, Hu Y, Li F, et al. Family outbreak of severe pneumonia induced by H7N9 infection. Am J Respir Crit Care Med 2013;188:114-5.
European Centre for Disease Prevention and Control. Rapid Risk Assessment. Human Infection with Avian Influenza A viruses, China. Stockholm: ECDC; 2014.
To KK, Song W, Lau SY, Que TL, Lung DC, Hung IF, et al. Unique reassortant of influenza A(H7N9) virus associated with severe disease emerging in Hong Kong. J Infect 2014;69:60-8.
Ho PL, Sin WC, Chan JF, Cheng VC, Chan KH. Severe influenza A H7N9 pneumonia with rapid virological response to intravenous zanamivir. Eur Respir J 2014;44:535-7.
Okomo-Adhiambo M, Fry AM, Su S, Nguyen HT, Elal AA, Negron E, et al. Oseltamivir-resistant influenza A(H1N1)pdm09 viruses, United States, 2013-14. Emerg Infect Dis 2015;21:136-41.
Qi Y, Fan H, Qi X, Zhu Z, Guo X, Chen Y, et al. A novel pyrosequencing assay for the detection of neuraminidase inhibitor resistance-conferring mutations among clinical isolates of avian H7N9 influenza virus. Virus Res 2014;179:119-24.
Downloads
Published
How to Cite
Issue
Section
Downloads
License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.